The World Health Organisation (WHO) has prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency, a critical tool for safely administering WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) malaria.
Trending
- PDP Sokoto appoints new State women leader, zonal secretary
- Association postpones youth drug abuse forum in Sokoto
- Association inaugurates motorised borehole in Edo community to combat water scarcity
- Experts call for better hygiene, water, nutrition to reduce child diarrhoea
- Abandon hoes, cutlasses for modern farming – Tinubu’s Wife urges Nigerians
- Economist urges stronger reforms to fix Nigeria’s electricity crisis
- NMDPRA: Dangote refinery’s aviation fuel price will ensure market stability
- UN raises alarm over rising attacks on journalists
